3.4 SURMOUNT1 Trial SURMOUNT-1 trial was a randomized, double-blind, placebo-controlled phase 3 trial evaluating the safety and efficacy of tirzepatide in 2539 obese (BMI 30) or overweight (BMI 27) adult patients with at least one weight-related comorbidity, excluding diabetes
1 2 "Folate deficiency: MedlinePlus Medical Encyclopedia"
In patients with autoimmune thyroiditis (predominantly Hashimotos disease), the body produces antibodies that attack the thyroid gland, and levels of these antibodies in blood can diagnose this condition and indicate the extent of the disease
The following table provides a clinically useful framework
How does GLP-1 help with weight loss
Discussion In this study, we have developed a novel AML-specific drug-delivery system, TLR2 pep conjugated oridonin-liposome